SG11201601714UA - Novel triazolo[4,5-d]pyrimidine derivatives - Google Patents
Novel triazolo[4,5-d]pyrimidine derivativesInfo
- Publication number
- SG11201601714UA SG11201601714UA SG11201601714UA SG11201601714UA SG11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA SG 11201601714U A SG11201601714U A SG 11201601714UA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrimidine derivatives
- novel triazolo
- triazolo
- novel
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13183385 | 2013-09-06 | ||
| PCT/EP2014/068640 WO2015032769A1 (en) | 2013-09-06 | 2014-09-03 | Novel triazolo[4,5-d]pyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601714UA true SG11201601714UA (en) | 2016-04-28 |
Family
ID=49111076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601714UA SG11201601714UA (en) | 2013-09-06 | 2014-09-03 | Novel triazolo[4,5-d]pyrimidine derivatives |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US9593123B2 (sl) |
| EP (3) | EP3041843B1 (sl) |
| JP (1) | JP6441356B2 (sl) |
| KR (3) | KR102349567B1 (sl) |
| CN (1) | CN105555788B (sl) |
| AR (1) | AR097553A1 (sl) |
| AU (1) | AU2014317229B2 (sl) |
| CA (1) | CA2915766C (sl) |
| CL (1) | CL2016000495A1 (sl) |
| CR (1) | CR20160076A (sl) |
| DK (2) | DK3041843T3 (sl) |
| EA (1) | EA028335B1 (sl) |
| ES (2) | ES2714094T3 (sl) |
| HK (1) | HK1219277A1 (sl) |
| HR (2) | HRP20190361T1 (sl) |
| HU (2) | HUE041760T2 (sl) |
| IL (1) | IL243092B (sl) |
| LT (2) | LT3483163T (sl) |
| MA (1) | MA38826B1 (sl) |
| MX (2) | MX367084B (sl) |
| MY (1) | MY191628A (sl) |
| PE (2) | PE20191528A1 (sl) |
| PH (1) | PH12016500250B1 (sl) |
| PL (2) | PL3041843T3 (sl) |
| PT (2) | PT3483163T (sl) |
| RS (2) | RS62234B1 (sl) |
| SG (1) | SG11201601714UA (sl) |
| SI (2) | SI3041843T1 (sl) |
| TR (1) | TR201900662T4 (sl) |
| TW (1) | TWI705966B (sl) |
| UA (1) | UA116395C2 (sl) |
| WO (1) | WO2015032769A1 (sl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015162630A1 (en) * | 2014-04-25 | 2015-10-29 | Anlon Chemical Research Organization | Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis. |
| EA031735B1 (ru) | 2014-11-07 | 2019-02-28 | Ф. Хоффманн-Ля Рош Аг | ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2 |
| WO2017004133A1 (en) * | 2015-06-29 | 2017-01-05 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| CN109232694A (zh) * | 2015-11-06 | 2019-01-18 | 江苏恒瑞医药股份有限公司 | 制备坎格雷洛中间体的方法 |
| EP3475280B1 (en) | 2016-06-23 | 2020-04-08 | H. Hoffnabb-La Roche Ag | Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives |
| WO2018015088A1 (en) | 2016-06-23 | 2018-01-25 | F. Hoffmann-La Roche Ag | Novel [1,2,31triazolo[4,5-d]pyrimidine derivatives |
| WO2017220544A1 (en) | 2016-06-23 | 2017-12-28 | F. Hoffmann-La Roche Ag | Novel[1,2,3]triazolo[4,5-d]pyrimidine derivatives |
| UA123834C2 (uk) * | 2016-06-23 | 2021-06-09 | Ф. Хоффманн-Ля Рош Аг | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ З АФІННІСТЮ ДО КАНАБІНОЇДНИХ РЕЦЕПТОРІВ ТИПУ 2 |
| CN106478639B (zh) * | 2016-09-05 | 2018-09-18 | 郑州大学 | 嘧啶并1,2,4–三氮唑类的lsd1抑制剂、其制备方法及应用 |
| CN106432248B (zh) * | 2016-09-27 | 2018-11-27 | 郑州大学 | 含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用 |
| CN106432247B (zh) * | 2016-09-27 | 2018-06-29 | 郑州大学 | 含有腙键的嘧啶并三氮唑类化合物、制备方法及其应用 |
| CN106928296A (zh) * | 2017-02-06 | 2017-07-07 | 上海华升生物科技有限公司 | 一种2‑(3,3,3‑三氟丙硫基)腺苷的合成方法 |
| CN107033148B (zh) * | 2017-05-03 | 2018-10-26 | 郑州大学 | 含嘧啶并三氮唑—巯基四氮唑类lsd1抑制剂、其制备方法及应用 |
| CN106928235A (zh) * | 2017-05-03 | 2017-07-07 | 郑州大学 | 含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用 |
| CN109516990B (zh) * | 2017-09-19 | 2021-06-01 | 天津药物研究院有限公司 | 嘧啶并三氮唑类化合物、其制备方法和用途 |
| CN113582935A (zh) * | 2021-08-27 | 2021-11-02 | 中国医学科学院放射医学研究所 | 一种炎症小体核苷酸结合寡聚化结构域样受体蛋白3抑制剂及其制备方法和应用 |
| CN115246832B (zh) * | 2022-06-15 | 2024-05-24 | 深圳湾实验室 | 一类去泛素化酶usp25和usp28靶向抑制剂及制备和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1278819A (zh) | 1997-09-02 | 2001-01-03 | 杜邦药品公司 | 作为促肾上腺皮质素释放激素拮抗剂、可用于治疗cns障碍和紧张相关性疾病的杂环基取代的环稠合吡啶和嘧啶 |
| JP2004502642A (ja) | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| CN101060841A (zh) * | 2004-06-17 | 2007-10-24 | 加利福尼亚大学董事会 | 拮抗腺苷a2a受体来改善成瘾行为的一种或多种构成 |
| AR051596A1 (es) | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
| CN101855222A (zh) | 2007-05-10 | 2010-10-06 | 通用电气健康护理有限公司 | 对大麻素cb2受体具有活性的咪唑并(1,2-a)吡啶和相关化合物 |
| JP2011507910A (ja) * | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
| US9271962B2 (en) | 2008-03-17 | 2016-03-01 | Northeastern University | Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| WO2010120987A1 (en) | 2009-04-17 | 2010-10-21 | Wyeth Llc | Ring fused, ureidoaryl- and carbamoylaryl-bridged morpholino-pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| PL2771326T4 (pl) | 2011-10-27 | 2018-06-29 | Lek Pharmaceuticals D.D. | Synteza związków triazolopirymidynowych |
| UA111640C2 (uk) * | 2011-11-08 | 2016-05-25 | Ф. Хоффманн-Ля Рош Аг | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2 |
| US9067943B2 (en) * | 2011-11-25 | 2015-06-30 | Hoffmann-La Roche Inc. | [1,2,3]triazolo[4,5-D]pyrimidine derivatives |
| WO2014005968A1 (en) | 2012-07-04 | 2014-01-09 | F. Hoffmann-La Roche Ag | Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
| EA027780B1 (ru) | 2012-12-07 | 2017-08-31 | Ф.Хоффманн-Ля Рош Аг | Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2 |
| LT2928881T (lt) | 2012-12-07 | 2018-06-11 | F. Hoffmann-La Roche Ag | Nauji piridino dariniai |
| EA025841B1 (ru) | 2012-12-07 | 2017-02-28 | Ф. Хоффманн-Ля Рош Аг | Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2 |
| IN2015DN03145A (sl) | 2012-12-07 | 2015-10-02 | Hoffmann La Roche | |
| MY176797A (en) | 2013-03-07 | 2020-08-21 | Hoffmann La Roche | Novel pyrazol derivatives |
| EP2991988B1 (en) | 2013-05-02 | 2017-05-31 | F. Hoffmann-La Roche AG | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists |
| WO2014177490A1 (en) | 2013-05-02 | 2014-11-06 | F. Hoffmann-La Roche Ag | Purine derivatives as cb2 receptor agonists |
| ES2641210T3 (es) | 2013-06-11 | 2017-11-08 | F. Hoffmann-La Roche Ag | Derivados de tetrazolona |
-
2014
- 2014-09-03 WO PCT/EP2014/068640 patent/WO2015032769A1/en active Application Filing
- 2014-09-03 PE PE2019001869A patent/PE20191528A1/es unknown
- 2014-09-03 SG SG11201601714UA patent/SG11201601714UA/en unknown
- 2014-09-03 EP EP14761320.2A patent/EP3041843B1/en active Active
- 2014-09-03 CA CA2915766A patent/CA2915766C/en active Active
- 2014-09-03 PE PE2015002700A patent/PE20160691A1/es unknown
- 2014-09-03 EP EP21179163.7A patent/EP3943497A1/en active Pending
- 2014-09-03 DK DK14761320.2T patent/DK3041843T3/en active
- 2014-09-03 UA UAA201603048A patent/UA116395C2/uk unknown
- 2014-09-03 LT LTEP18206943.5T patent/LT3483163T/lt unknown
- 2014-09-03 LT LTEP14761320.2T patent/LT3041843T/lt unknown
- 2014-09-03 KR KR1020167008516A patent/KR102349567B1/ko active IP Right Grant
- 2014-09-03 HU HUE14761320A patent/HUE041760T2/hu unknown
- 2014-09-03 ES ES14761320T patent/ES2714094T3/es active Active
- 2014-09-03 JP JP2016539509A patent/JP6441356B2/ja active Active
- 2014-09-03 CN CN201480048593.7A patent/CN105555788B/zh active Active
- 2014-09-03 DK DK18206943.5T patent/DK3483163T3/da active
- 2014-09-03 MX MX2016002117A patent/MX367084B/es active IP Right Grant
- 2014-09-03 SI SI201431099T patent/SI3041843T1/sl unknown
- 2014-09-03 EP EP18206943.5A patent/EP3483163B1/en active Active
- 2014-09-03 HU HUE18206943A patent/HUE055201T2/hu unknown
- 2014-09-03 PL PL14761320T patent/PL3041843T3/pl unknown
- 2014-09-03 PL PL18206943T patent/PL3483163T3/pl unknown
- 2014-09-03 PT PT182069435T patent/PT3483163T/pt unknown
- 2014-09-03 TR TR2019/00662T patent/TR201900662T4/tr unknown
- 2014-09-03 PT PT14761320T patent/PT3041843T/pt unknown
- 2014-09-03 RS RS20211007A patent/RS62234B1/sr unknown
- 2014-09-03 KR KR1020217017887A patent/KR102454344B1/ko active Application Filing
- 2014-09-03 SI SI201431869T patent/SI3483163T1/sl unknown
- 2014-09-03 MY MYPI2016700721A patent/MY191628A/en unknown
- 2014-09-03 ES ES18206943T patent/ES2883923T3/es active Active
- 2014-09-03 RS RS20190264A patent/RS58390B1/sr unknown
- 2014-09-03 KR KR1020227034655A patent/KR20220140651A/ko not_active Application Discontinuation
- 2014-09-03 AU AU2014317229A patent/AU2014317229B2/en active Active
- 2014-09-03 EA EA201690478A patent/EA028335B1/ru not_active IP Right Cessation
- 2014-09-04 AR ARP140103305A patent/AR097553A1/es active IP Right Grant
- 2014-09-04 TW TW103130651A patent/TWI705966B/zh active
-
2015
- 2015-12-14 IL IL243092A patent/IL243092B/en active IP Right Grant
-
2016
- 2016-02-04 MA MA38826A patent/MA38826B1/fr unknown
- 2016-02-04 PH PH12016500250A patent/PH12016500250B1/en unknown
- 2016-02-16 CR CR20160076A patent/CR20160076A/es unknown
- 2016-02-17 MX MX2019009100A patent/MX2019009100A/es unknown
- 2016-02-23 US US15/050,753 patent/US9593123B2/en active Active
- 2016-03-04 CL CL2016000495A patent/CL2016000495A1/es unknown
- 2016-06-23 HK HK16107348.6A patent/HK1219277A1/zh unknown
-
2019
- 2019-02-25 HR HRP20190361TT patent/HRP20190361T1/hr unknown
-
2021
- 2021-08-16 HR HRP20211322TT patent/HRP20211322T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL243092A0 (en) | New triazolo[d–4,5]pyrimidine histories | |
| HRP20181349T1 (hr) | Derivat tetrahidroimidazo[1,5-d][1,4]oksazepina | |
| HK1245764A1 (zh) | 3-取代的5-氨基-6h-噻唑並[4，5-d]嘧啶-2，7-二酮化合物 | |
| ZA201506570B (en) | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents | |
| IL254224A0 (en) | 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors | |
| HK1206014A1 (en) | Pyrazolo triazine derivatives as selective cyclin dependent kinase inhinitors | |
| EP3067356A4 (en) | Pyrrolo pyrimidine derivative | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| PL2694513T3 (pl) | Pochodne pirazolopirymidynowe | |
| ZA201507151B (en) | Antiviral indolo[2,3-b]quinoxaline | |
| TH1601001194A (th) | อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่ | |
| GB201219129D0 (en) | Triazolo(4,5-d)pyrmindine compounds |